Evidence map›Paper›PMID 38865972›Full record

ArticleNeuro-degenerative diseases2024

Classification of Mild Cognitive Impairment and Alzheimer's Disease Using Manual Motor Measures.

Vincent Koppelmans, Marit F L Ruitenberg, Sydney Y Schaefer, Jace B King, Jasmine M Jacobo, Benjamin P Silvester, Amanda F Mejia, Jos van der Geest, John M Hoffman, Tolga Tasdizen and 1 more

Abstract read
In one paragraph

Article in Neuro-degenerative diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vincent KoppelmansDepartment of Psychiatry, University of Utah, Salt Lake City, Utah, USA.
Marit F L RuitenbergDepartment of Health, Medical and Neuropsychology, Leiden University, Leiden, The Netherlands.
Sydney Y SchaeferSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona, USA.
Jace B KingDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA.
Jasmine M JacoboDepartment of Psychiatry, University of Utah, Salt Lake City, Utah, USA.
Benjamin P SilvesterDepartment of Psychiatry, University of Utah, Salt Lake City, Utah, USA.
Amanda F MejiaDepartment of Statistics, University of Indiana, Bloomington, Indiana, USA.
Jos van der GeestDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
John M HoffmanDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA.
Tolga TasdizenElectrical and Computer Engineering, University of Utah, Salt Lake City, Utah, USA.
Kevin DuffDepartment of Neurology, Oregon Health & Science University, Portland, Oregon, USA.

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Randall L Woltjer · 2020 to 2026
$28.6M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI ALIREZA ATRI · 2021 to 2026
$24.9M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Enriching clinical trials requiring amyloid positivity with practice effectsR01AG055428 · NIA · UNIVERSITY OF UTAH · PI DUFF, KEVIN M, HOFFMAN, JOHN M · 2017 to 2021
$3.6M
Motor Profiles as Novel Biomarker for Alzheimer’s DiseaseK01AG073578 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KOPPELMANS, VINCENT · 2021 to 2025
$651k
Novel metrics of brain dynamics in Alzheimer’s diseaseK01AG075166 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jace Bradford King · 2022 to 2026
$651k
NCATS NIH HHS UM1 TR004409NIA NIH HHS K01 AG073578NIA NIH HHS K01 AG075166NIA NIH HHS P30 AG066518NIA NIH HHS P30 AG072980NIA NIH HHS R01 AG055428
6 · The paper itself

Abstract

introductionManual motor problems have been reported in mild cognitive impairment (MCI) and Alzheimer's disease (AD), but the specific aspects that are affected, their neuropathology, and potential value for classification modeling is unknown. The current study examined if multiple measures of motor strength, dexterity, and speed are affected in MCI and AD, related to AD biomarkers, and are able to classify MCI or AD.

methodsFifty-three cognitively normal (CN), 33 amnestic MCI, and 28 AD subjects completed five manual motor measures: grip force, Trail Making Test A, spiral tracing, finger tapping, and a simulated feeding task. Analyses included (1) group differences in manual performance; (2) associations between manual function and AD biomarkers (PET amyloid β, hippocampal volume, and APOE ε4 alleles); and (3) group classification accuracy of manual motor function using machine learning.

resultsAmnestic MCI and AD subjects exhibited slower psychomotor speed and AD subjects had weaker dominant hand grip strength than CN subjects. Performance on these measures was related to amyloid β deposition (both) and hippocampal volume (psychomotor speed only). Support vector classification well-discriminated control and AD subjects (area under the curve of 0.73 and 0.77, respectively) but poorly discriminated MCI from controls or AD.

conclusionGrip strength and spiral tracing appear preserved, while psychomotor speed is affected in amnestic MCI and AD. The association of motor performance with amyloid β deposition and atrophy could indicate that this is due to amyloid deposition in and atrophy of motor brain regions, which generally occurs later in the disease process. The promising discriminatory abilities of manual motor measures for AD emphasize their value alongside other cognitive and motor assessment outcomes in classification and prediction models, as well as potential enrichment of outcome variables in AD clinical trials.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgedAged, 80 and overAmyloid beta-PeptidesFemaleHand StrengthHippocampusHumansMaleMiddle AgedNeuropsychological TestsPositron-Emission TomographyPsychomotor PerformanceAmyloid beta-PeptidesAlzheimer’s diseaseBiomarkersMachine learningManual dexterityMotor function

Identifiers

PMID38865972
PMCPMC11381162

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.